Investigative Ophthalmology & Visual Science Cover Image for Volume 61, Issue 7
June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Molecular Differences in Segmental Flow Cells from Human Trabecular Meshwork
Author Affiliations & Notes
  • Janice A Vranka
    Department of Basic Science, University of Houston, Houston, Texas, United States
  • Julia Staverosky
    Ophthalmology, Casey Eye Inst/Oregon Hlth & Sci Univ, Portland, Oregon, United States
  • Kamesh Dhamodaran
    Department of Basic Science, University of Houston, Houston, Texas, United States
  • Vijaykrishna Raghunathan
    Department of Basic Science, University of Houston, Houston, Texas, United States
    College of Optometry, University of Houston, Houston, Texas, United States
  • Footnotes
    Commercial Relationships   Janice Vranka, None; Julia Staverosky, None; Kamesh Dhamodaran, None; Vijaykrishna Raghunathan, None
  • Footnotes
    Support  NIH/NEI grants EY026048-01A1 (JAV, VKR), P30 EY010572, and by an unrestricted grant to the Casey Eye Institute from Research to Prevent Blindness, New York, NY.
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 3469. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Janice A Vranka, Julia Staverosky, Kamesh Dhamodaran, Vijaykrishna Raghunathan; Molecular Differences in Segmental Flow Cells from Human Trabecular Meshwork. Invest. Ophthalmol. Vis. Sci. 2020;61(7):3469.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Altered tissue biomechanics have long been known to be associated with glaucoma, though the underlying molecular mechanisms are poorly understood. Recent studies have shown that glaucomatous trabecular meshwork (TM) tissue is markedly stiffer than age-matched control, and this stiffness difference appears to be localized in the low flow regions of the TM. The goal of this study was to determine the underlying mechanism of the stiffness differences by measuring crosslinking in segmental flow cells and tissues from the TM.

Methods : Primary cells were cultured from high (HF) and low (LF) flow regions of human TM tissues from multiple donor eyes (n = 4 non-glaucoma, n= 3 glaucoma donors). Cells were grown to confluence for up to 2 weeks and serum-free conditioned medium was collected. Total protein concentration was determined by BCA assay and samples were normalized to total protein levels. Samples were subsequently subjected to tissue transglutaminase (TGM2) and lysyl oxidase (LOX) enzyme activity assays to compare crosslinking activities. Immunohistochemistry and western blots were also performed to assess crosslinking protein levels. Quantitative RT-PCR was performed to measure TGM2 and LOX gene levels in HF and LF cells.

Results : Conditioned medium from HF and LF cell strains (n = 4 biological replicates) showed differences in TGM2 and LOX enzyme activities, as well as some differences in overall crosslinking gene and protein expression levels. Differences in measured enzyme activities between cells from HF and LF cells were also evaluated from glaucomatous eyes. Differences observed in protein expression in tissues ex vivo was modest in comparison with those observed between cells in vitro.

Conclusions : Our data demonstrate that differences in crosslinking enzyme activities observed between segmental cells exist and correlate with tissue stiffness reported previously. HF and LF TM cell strains are a new tool used here to dissect the molecular mechanisms of segmental flow and its relationship to extracellular matrix crosslinking and biomechanics. Further studies are required to dissect their roles in homeostasis and outflow regulation in pathology.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×